The foundation:

Fundació ACE presents 5 posters at the AAIC 2018


Fundació ACE participates this year in July 22-26 in Chicago at the Alzheimer's Association International Conference 2018 (AAIC) by presenting 5 posters.

The AICC, organized by the prestigious American entity Alzheimer's Association, is one of the leading international events within the Alzheimer's and dementia sector.

Leaders and experts from more than 70 countries meet each year at the AAIC, which usually lasts 4 days. The conference is a platform for leading initiatives in Alzheimer's and to present the latest dementia research study results in all fields related to dementia and Alzheimer's.

The scientific team of Fundació ACE has achieved a place in the Alzheimer's Association International Conference 2018 for 5 of the studies carried out in the Diagnostic Unit and the Research Unit.  


July 22

Non-Scheduled Consultations Can Help to Identify Highly Demanding Dementia Patients.

Isabel Hernandez MD PhD, Carla Abdelnour MD, Sergi Valero PhD, Pilar Canabate PhD, Ana Mauleon  MD, Maitee Rosende-Roca MD, Liliana Vargas MD, Octavio Rodriguez-Gomez MD, Silvia Gil MD PhD, Miguel Santos MD PhD, Marta Marquie MD PhD, Mariola Moreno Ms, Silvia Preckler , Agustin Ruiz MD PhD, Lluis Tarraga MSc and Merce Boada MD PhD. Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.  


APOE Status Modulates Brain Patterns of Amyloid Distribution in Individuals with Subjective Cognitive Decline (SCD) from the FACEHBI study.

Mercè Boada, MD, PhD1 ,Octavio Rodriguez-Gomez, MD1, Silvia Gil, MD, PhD1, Angela Sanabria PhD1, Montse Alegret, PhD1, Alba Perez-Cordón MSc1, Francisco Lomeña PhD2, Javier Pavia PhD2, Rossella GismondimPhD3, Santi Bullich PhD3, Assumpta Vivas-Larruy MD4, Marta Gomez-Chiari MD4, Begoña Hernández-Olasagarre, PhD 1, Adela Orellana, PhD 1, Sergi Valero, PhD 1, Agustín Ruiz, MD, PhD 1, Lluís Tárraga, MSc1, Gemma Monté-Rubio, PhD1and the FACEHBI Study Group. 1.Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain. 2. Department of Nuclear Medicine. Hospital Clínic de Barcelona. 3. Piramal Imaging. Berlin. Germany. 4. Department of Radiology. Clinica Corachan. Barcelona. Spain.  


July 23

Genome-Wide Association Study of Alzheimer’s Disease (AD) Susceptibility Using the Fundació ACE Genome Repository. The GR@ACE Project.

Sonia Moreno-Grau, MS1, Isabel Hernandez, MD, PhD2, Begoña Hernández-Olasagarre, PhD 1, Inés Quintanela3 , Laura Montrreal1, Itziar de Rojas, MSc1, Montserrat Alegret, PhD 4 , Antonio González-Pérez, PhD 5, Gemma Monté-Rubio1,Sergi Valero1 , Lluis Miguel Real6, Angel Carracedo3,7, María Eugenia Sáez, Ph.D.5 , Adelina Orellana, PhD1,Lluis Tarraga, MSc4, Mercè Boada, MD, PhD1,2,4 and Agustín Ruiz Ruiz, MD, PhD1,4,8. 1.Neuroscience Center. Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain. 2. Fundació ACE. Barcelona Alzheimer Treatment and Research Center, Barcelona, Spain. 3. Grupo de Medicina Xenómica, Centro Nacional Genotipado (CEGEN-PRB3-ISCIII). Universidad de Santiago de Compostela, Santiago de Compostela, Spain. 4. Fundació ACE. Barcelona Alzheimer Treatment & Research Center, Barcelona, Spain. 5. CAEBI. Centro Andaluz de Estudios Bioinformáticos., Sevilla, Spain. 6.Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain. 7. Fundación Pública Galega de Medicina Xenómica-CIBERER-IDIS, Santiago de Compostela, Spain. 8. Facultat de Medicina i Ciències de la Salut. Universitat Internacional de Catalunya (UIC), Sant Cugat de Vallès, Spain.  


July 24

Models of Patient Engagement in Alzheimer´s Disease (MOPEAD): a European multinational project to develop and test innovative patient engagement strategies.

Octavio Rodríguez-Gómez MD.1, Laura Campo PhD.2Hans P Hundemer MD,2 Bengt Winblad MD, PhD.4  Frank Jessen, MD.5 Pieter Jelle Visser, MD PhD.6 Milica G Kramberger, MD, PhD.7 Rafael Simó, MD, PhD.Adrián Rodrigo. 9 Annette Dumas.10 Jean Georges, BA.11 David Krivec.12 Peggy Maguire.13 Derek McKenzie14 and Mercè Boada MD PhD1  


Looking for therapeutic entry points for Alzheimer’s disease: lessons learned from agnostic trans-co-regulatory network analyses of APOE, TREM2, PLCG2 and ABI3 loci. Agustín Ruiz M.D. Ph.D.1,2, Laura Madrid Ph.D.3 Itziar de Rojas M.S.1, Antonio González-Pérez Ph.D.3, Santos Mañes Ph.D.4, Alfredo Ramírez M.D. Ph.D.5, Begoña Hernández-Olasagarre Ph.D. 1, María Eugenia Sáez Ph.D.3  


AAIC 2018  

AAIC 2018  

AAIC 2018  

AAIC 2018  



You might also like

IMI Stakeholder Forum 2019

Fundación ACE attended this year the IMI Stakeholder Forum 2019, focused on health and brain diseases in the digital era.